VLB 01

Drug Profile

VLB 01

Alternative Names: AED; Beprodon; beprodone; Remegal; VLB-01

Latest Information Update: 26 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MarcoPolo Pharmaceuticals SA
  • Class Antiepileptic drugs
  • Mechanism of Action Melatonin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Partial epilepsies

Most Recent Events

  • 12 Feb 2016 No development reported - Phase-III for Partial epilepsies (Adjuvant therapy) in Russia (unspecified route)
  • 01 Mar 2012 Phase-III clinical trials in Partial seizures (adjunctive therapy) in Russia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top